However, Metzeler et al. failed to confirm these results and observed no negative clinical impact of PTPN11 mutations in a cohort of 116 newly diagnosed PTPN11-mut AML patients [92]. The gene discussed is PTPN11; the disease is acute myeloid leukemia.